All data are based on the daily closing price as of October 8, 2025
s

Sam Chun Dang Pharm

000250.KQ
153.79 USD
3.35
+2.23%

Overview

Last close
153.79 usd
Market cap
3.29B usd
52 week high
185.16 usd
52 week low
61.87 usd
Target price
43.49 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
23.362
Price/Book Value
19.4019
Enterprise Value
3.48B usd
EV/Revenue
23.0496
EV/EBITDA
343.6858

Key financials

Revenue TTM
123.82M usd
Gross Profit TTM
58.10M usd
EBITDA TTM
12.44M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
359.28M usd
Net debt
N/A usd

About

Sam Chun Dang Pharm. Co., Ltd manufactures, distributes, imports, and exports pharmaceuticals in South Korea. It provides ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company was founded in 1943 and is headquartered in Seoul, South Korea.
  • Symbol
    000250.KQ
  • Exchange
    KQ
  • Isin
    KR7000250001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Pharmaceuticals
  • CEO
    Dae-In Yoon
  • Headquarter
    Seoul
  • Web site
    https://www.scd.co.kr

Related news

Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top